You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 4, April 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Feature
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •HIV/AIDS
 •Viral Infections
 •Dermatology
 •Dermatologic Disorders
 •Pediatrics, Other
 •Diagnosis
 •Picture of the Month
 •Dermatologic Disorders, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Picture of the Month—Diagnosis


Arch Pediatr Adolesc Med. 2009;163(4):384.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Denouement and Discussion: Molluscum Contagiosum

The findings of smooth, waxy umbilicated papules as seen in our case are characteristic of molluscum contagiosum. The patient was also diagnosed with human immunodeficiency virus infection with low CD4+ T-cell counts. A regression of the skin lesions was seen after commencement of highly active antiretroviral therapy.

Molluscum contagiosum is a viral disorder of the skin characterized by discrete, single or multiple, flesh-colored papules. It is caused by Molluscipoxvirus, a large, double-stranded-DNA virus belonging to the same family as cowpox and smallpox.1 There are 4 subtypes, all of which behave clinically identically. Subtype I (75%-90% of cases) is the most common, followed by subtype II.2

Molluscum contagiosum occurs in 2% to 8% of immunocompetent children and in 10% to 20% of human immunodeficiency virus–positive patients; the prevalence in patients with human immunodeficiency virus infection is directly related to the degree of immunocompromise. Since the introduction of highly active antiretroviral . . . [Full Text of this Article]


AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Picture of the Month—Quiz Case
Sunita Juliana Ferns and Peter A. Noronha
Arch Pediatr Adolesc Med. 2009;163(4):383.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.